Cisplatin chemosensitivity assay showed that forced expression of microRNA‐433‐3p in HS683/DDP cell line markedly promoted sensitivity of glioma cells to cisplatin, while NR5A2 could reverse the promotion of microRNA‐433‐3p on glioma cell sensitivity to cisplatin (Figure 4f). This evidence concerns the gene NR5A2 and glioma.